脑部放疗，上午比下午敏感许多！
) T. D: F$ U7 x+ P2 N/ P. V6 u1 {0 @: H- n! n0 j. F+ Z @8 m) P
$ }/ a6 H% [9 f, U0 \1 ZCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9. Y. l$ i c# B; g. P
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?- }" P8 q9 ^ l( R
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T." v. @% [# h6 W
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
* Z) m) ^. M& I6 w# U* g# b0 {# ^9 v% J0 [1 {3 O- t
Abstract
3 k+ F" V5 {/ ]# dBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
6 d' C/ G& s. n& d' O* |
( D% b# O) e4 K) p% y, YMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
& K, h: r. z7 ^' Y2 n
% B+ J4 k4 M; P! |% y/ uRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)., B8 V2 |6 i" l7 E q2 ]' f( _& _
9 I" i* C3 N, A" j
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
- S/ s! ?$ M+ I* Q( A. {9 y
' v$ K. s0 w, z( ~5 @ |
2 k) Y% e/ E& D( R' X+ Y2 a# R
显身卡
